Cepton, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q1 FY2021 As of Feb 22, 2021	Q4 FY2012 As of Dec 31, 2012	Q3 FY2012 As of Sep 30, 2012	Q2 FY2012 As of Jun 30, 2012	Q1 FY2012 As of Mar 31, 2012
ASSETS
Cash
Prepaid expenses
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net of allowance for credit losses of $0 and $0 (including $248 and $2,121 from a related party)
Inventories
Right-of-use assets
Operating lease right-of-use assets, current
Prepaid expenses and other current assets
Total current assets
Investments held in Trust Account
Property and equipment, net
Restricted cash
Other assets
Total assets
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Franchise tax payable
Accounts payable
Operating lease liabilities, current
Accrued expenses and other current liabilities
Short-term debt
Accrued expenses and other current liabilities (including $2,308 and $385 with a related party)
Promissory notes payable - related parties
Total current liabilities
Warrant liability

Long-term debt
Warrant liability
Earnout liability
Other long-term liabilities
Warrant liability
Earnout liability
Other long-term liabilities
Operating lease liabilities, non-current
Total liabilities
Class A common stock subject to possible redemption; 17,250,000 shares at December 31, 2021 and March 31, 2021, respectively (at redemption value of $10.00 per share)
Convertible preferred stock – Par value $0.00001 per share – No shares authorized at September 30, 2022; 22,806,009 shares authorized at December 31, 2021; No shares issued and outstanding at September 30, 2022; 21,671,491 shares issued and outstanding at December 31, 2021 (aggregate liquidation preference of $96.7 million at December 31, 2021)
Convertible preferred stock with a related party:
Convertible preferred stock – Par value $0.00001 per share – 5,000,000 shares authorized; 100,000 shares issued and outstanding (aggregate liquidation preference of $107.4 million and $104.1 million)
Stockholders’ equity (deficit):
Preferred stock - Par value $0.00001 per share – 5,000,000 shares authorized at December 31, 2022; No shares authorized at December 31, 2021; No shares issued and outstanding at December 31, 2022 or 2021
Common stock
Common Stock
Class B Common Stock
Class F Stock
Total common stock

Class B common stock, $0.0001 par value, 10,000,000 shares authorized, 4,312,500 shares issued and outstanding at December 31, 2021 and March 31, 2021
Additional paid-in capital
Deficit accumulated during development stage
Total stockholders' (deficiency) equity
Accumulated other comprehensive loss
Accumulated deficit
Common Stock
Class B Common Stock
Total stockholders’ equity (deficit)

Total liabilities, convertible preferred stock and stockholders’ equity (deficit)

Comments